Novel therapies emerge for a progressive corneal disease
Fuchs endothelial corneal dystrophy (FECD) is a common corneal disease that affects 4% to 7% of people in the US.1 FECD is a progressive dysfunction of the corneal endothelium characterised by abnormal endothelial morphology (pleomorphism and polymegethism …